Pharmaceutical giants AstraZeneca and Merck said Thursday they had agreed a multi-billion-dollar deal to jointly develop key cancer drugs. "The strategic collaboration is expected to further increase the number of treatment options available to patients," British company AstraZeneca and its US peer said in a statement. Merck will pay AstraZeneca up to $8.5 billion (7.2 billion euros) under the deal struck to develop and commercialise the drugs. source:AFP
GMT 19:13 2018 Monday ,15 January
The Cranberries singer Dolores O'Riordan dies aged 46GMT 20:53 2018 Monday ,08 January
UK minister resigns after rejecting PM's reshuffleGMT 16:28 2018 Monday ,08 January
British PM begins reshuffle by naming new party chairmanGMT 10:38 2017 Wednesday ,27 December
M1 shut and 24,000 without power as snow hits UKGMT 18:27 2017 Tuesday ,26 December
Quieter than expected trading for stores on Boxing DayMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©